Amgen Inc SEC filings AMGN
Amgen Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | Feb 19, 2026 | — |
| FWP | Free writing prospectus | Feb 17, 2026 | — |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 13, 2026 | — |
| S-8 | Employee stock plan registration | Jun 12, 2024 | — |
| S-8 | Employee stock plan registration | Oct 6, 2023 | — |
| 424B2 | Prospectus | Feb 17, 2023 | — |
| FWP | Free writing prospectus | Feb 16, 2023 | — |
| 424B3 | Prospectus | Feb 14, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 9, 2023 | — |
| 424B2 | Prospectus | Aug 16, 2022 | — |
| FWP | Free writing prospectus | Aug 15, 2022 | — |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| 424B2 | Prospectus | Feb 18, 2022 | — |
| FWP | Free writing prospectus | Feb 17, 2022 | — |
| 424B3 | Prospectus | Feb 17, 2022 | — |
| S-8 | Employee stock plan registration | Nov 3, 2021 | — |
| S-8 | Employee stock plan registration | Nov 3, 2021 | — |
| 424B2 | Prospectus | Aug 6, 2021 | — |
| FWP | Free writing prospectus | Aug 6, 2021 | — |
| 424B3 | Prospectus | Aug 5, 2021 | — |
| 424B3 | Prospectus | Apr 15, 2021 | — |
| S-4/A | Filing | Apr 6, 2021 | — |
| S-4 | Registration for a merger or exchange | Feb 9, 2021 | — |
| 424B2 | Prospectus | May 6, 2020 | — |
| FWP | Free writing prospectus | May 5, 2020 | — |
| 424B3 | Prospectus | May 4, 2020 | — |
| 424B2 | Prospectus | Feb 20, 2020 | — |
| FWP | Free writing prospectus | Feb 18, 2020 | — |
| 424B3 | Prospectus | Feb 18, 2020 | — |
| S-3ASR | Automatic shelf registration | Feb 10, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AMGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Thousand Oaks, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 318154
Other Biological Products, (No Diagnostic Substances) companies
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.